Miho Kimura

Title: Miho Kimura: Innovator in Pharmaceutical Composition and Screening Systems

Introduction

Miho Kimura is a prominent inventor based in Ibaraki, Japan. She has made significant contributions to the field of pharmaceutical compositions and screening systems, particularly in relation to metabolic syndrome and blood glucose control. Her innovative work has led to the development of a unique method for screening substances that activate specific receptors associated with FGF21 activity.

Latest Patents

Miho Kimura holds a patent for a method that screens a test substance for activating a receptor associated with FGF21 activity. This patent, titled "Method for screening a test substance for activating a receptor associated with FGF 21 activity," describes a pharmaceutical composition that includes betaKlotho or a substance that modulates betaKlotho activity. The invention aims to provide therapeutic solutions for metabolic syndrome and control blood glucose levels. The patent also outlines a screening system that utilizes a cell system expressing an FGF receptor and/or betaKlotho.

Career Highlights

Miho Kimura is affiliated with the National Institute of Advanced Industrial Science and Technology, where she conducts her research and development. Her work has garnered attention for its potential impact on treating metabolic disorders and improving health outcomes.

Collaborations

Throughout her career, Miho has collaborated with notable colleagues, including Masashi Suzuki and Toru Imamura. These collaborations have contributed to the advancement of her research and the successful development of her patented technologies.

Conclusion

Miho Kimura is a trailblazer in the field of pharmaceutical innovation, with a focus on enhancing the understanding and treatment of metabolic syndrome. Her contributions through her patent and collaborative efforts highlight her commitment to advancing medical science and improving patient care.